Strategic Consulting.
Strategic Consulting.
Benefit Plan Assessment ✶
Benefit Plan Assessment ✶
Take control
of your pharmacy benefit spend with a
Appro-Intel Assessment.
-
Current PBM contract
Twelve-month file of claims and rebate activity.
Note: Plan sponsors are entitled by law to receive their claims data in a timely manner, even if a vendor suggests otherwise.
-
Independent review in minutes using real claim data, contract terms measured against industry standards, and factual financial outcomes.
Understand your true bottom line without assumptions, personal bias, or vendor influence.
Map contract language to real claim and rebate data
Show how definitions, pricing structures, specialty terms, and rebate mechanics translate into actual plan cost with supporting evidence
Clarify whether the plan is performing as intended
-
Net cost clarity
Trend analysis
Specialty impact
Hidden exposure areas
Biosimilar opportunities
Pricing inconsistencies
Where value is gained or lost
-
Renegotiate terms and correct weaknesses
Validate vendor performance
Capture savings while maintaining member access
Turn complex pharmacy economics into simple next steps
-
We walk you through the results and answer any questions.
You can use the findings to improve performance with your current PBM or explore Appro-Rx or trusted partners as an aligned alternative.
There is no risk and the potential for significant reward.
Plan Design Review ✶
Plan Design Review ✶
Take control
with our Pharmacist designed, Guideline-Driven
Plan Design and Claim Review
-
Current PBM Formulary
Twelve-month file of claims and rebate activity
Note: Plan sponsors are entitled by law to receive their claims data in a timely manner, even if a vendor suggests otherwise.
-
Recommends plan designs that result in positive patient outcomes
Provides strategies that improve cost efficiency without sacrificing care
Delivers pharmacist led insight on pharmacy market dynamics
Brings clarity to emerging drug and benefit trendsOffers practical guidance on how these factors affect your organization
-
Net cost optimization opportunities
Specialty and generic utilization trends
Specialty impact on total spend and opportunities for biosimilar or therapeutic interchanges
Lowest net cost formulary options
Biosimilar savings opportunities
Pricing inconsistencies across channels
Where value is gained or lost within the benefit structure
Prior Authorization, quantity limits, and day supply optimization
-
-
Minimum 15% Savings
with our Audit Tool
Before and After Drug Spend after Appro-Rx Audit and Consulting

